Markus Backmund

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.

J. Tilman Gerlach, Helmut M. Diepolder, Norbert H. Gruener et al. · Gastroenterology · 2003 · 521 citations · Full text

Pharmacy, Infectious Diseases, Hepatology +11

Treatment of Hepatitis C Infection in Injection Drug Users

Markus Backmund, Kirsten Meyer, Michael Von Zielonka et al. · Hepatology · 2001 · 258 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Recommendations for the management of hepatitis C virus infection among people who inject drugs

Jason Grebely, Geert Robaeys, Philip Bruggmann et al. · International Journal of Drug Policy · 2015 · 199 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +12

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 150 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutical Policy +13

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection†

Axel Ulsenheimer, J. Tilman Gerlach, Maria–Christina Jung et al. · Hepatology · 2005 · 120 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15